Browsing Tag
China
667 posts
SK Chemicals bets on feedstock certainty with Korea’s first vertical recycling chain
SK Chemicals’ joint venture with Kelinle brings Korea its first vertically integrated recycling value chain. Find out how this could change the plastics industry.
Leqembi gains traction in China as commercial insurance innovative drug list expands access for Alzheimer’s patients
Leqembi gains commercial insurance status in China, opening doors for Alzheimer’s patients and transforming access. Find out what this means for BioArctic AB and Eisai.
CARsgen showcases early clinical results for CT0596 allogeneic BCMA CAR-T cell therapy in multiple myeloma
CARsgen unveils early CT0596 CAR-T trial results at ASH 2025, showing deep responses and strong tolerability in multiple myeloma. See what’s next for the therapy.
India becomes Asia’s newest major power: What the 2025 Asia Power Index really tells us about regional influence
Find out how India’s new major power status in the 2025 Asia Power Index reshapes Asia’s strategic balance and what it means for regional geopolitics today.
HyperStrong and CATL ink 10-year strategic battery deal as 200 GWh supply commitment reshapes global energy storage
A decade-long HyperStrong and CATL alliance sets a new benchmark for global battery energy storage. Learn how their 200 GWh supply pact could shift the power market.
FSD in China by 2026? Tesla’s bet comes as EV rivals gain ground fast
Tesla expects full FSD approval in China by early 2026. Can this software milestone help reclaim market share from XPeng and Baidu?
Telitacicept delivers breakthrough proteinuria decline in Chinese IgA nephropathy phase 3 study
Find out how RemeGen’s Telitacicept achieved phase 3 success in reducing proteinuria for IgA nephropathy patients in China.
Tesla and XPeng see surging insurance premiums as SunCar expands its AI technology development center
Find out how SunCar’s AI technology center is driving explosive insurance-premium growth for Tesla and XPeng while reshaping the EV service ecosystem.
How Nvidia became the first $5 trillion company—and what it means for AI, investors, and global tech power plays
Discover how Nvidia just hit a historic $5 trillion valuation and what it means for the AI surge, investors and global tech markets—read more now!
Will orforglipron turn Eli Lilly into the king of GLP-1s? The FDA decision that could change obesity care
Eli Lilly is stockpiling orforglipron pills ahead of FDA approval. Explore the risks, rewards, and why investors are paying close attention to this launch.